Dr. Merlin Lee Robb, M.D. Pediatrics - Pediatric Infectious Diseases Medicare: Not Enrolled in Medicare Practice Location: Wramc, Bldg 2, Department Of Pediatrics, 6900 Georgia Avenue Nw, Washington Dc, DC 20307 Phone: 202-782-7250 Fax: 202-782-3800 |
Shaanan Meyerstein, Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Michigan Avenue Nw, Children's National Medical Center, Washington Dc, DC 20010 Phone: 202-476-5000 |
News Archive
Tolerx, Inc., a biopharmaceutical company developing novel therapies intended to treat diabetes, other autoimmune diseases and cancer by specifically modulating T-cell activity, today presented dose optimization data from its Phase 2 clinical study of otelixizumab in subjects with type 1 diabetes. Otelixizumab is a targeted T-cell immunomodulator currently being evaluated in DEFEND, a Phase 3 clinical study in subjects with new-onset autoimmune type 1 diabetes.
There are two major forms of kidney cancer. One is called renal cell cancer, which is an adenocarcinoma that occurs in the renal parenchyma. The other major type is called renal pelvis cancer, which is mostly of transitional cell type and they form in the centre of the kidney where the urine collects.
Patients with obstructive lung disease who take inhaled corticosteroids (ICS) may be at greater risk for nontuberculous mycobacteria pulmonary disease (NTM PD), according to new research presented at the ATS 2016 International Conference.
Scientists have made it easier to predict both breast cancer relapses and responses to chemotherapy, through the identification of a unique gene. The newly found marker could help doctors classify each breast cancer patient and customise a treatment regimen that is more effective.
› Verified 3 days ago